Carlos Iribarren to Disease Progression
This is a "connection" page, showing publications Carlos Iribarren has written about Disease Progression.
Connection Strength
0.070
-
Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab. J Allergy Clin Immunol. 2014 Sep; 134(3):560-567.e4.
Score: 0.027
-
Both pulmonary and extra-pulmonary factors predict the development of disability in chronic obstructive pulmonary disease. Respiration. 2013; 85(5):375-83.
Score: 0.024
-
Insulin resistance independently predicts the progression of coronary artery calcification. Am Heart J. 2009 May; 157(5):939-45.
Score: 0.019